CSPC Pharmaceutical Group Financial Overview
CSPC Pharmaceutical Group's market cap is currently $10.87B. The company's EPS TTM is $0.010474774000000001; its P/E ratio is 20.37; and it has a dividend yield of 3.09%. CSPC Pharmaceutical Group is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
